A randomized controlled study of finerenone versus placebo in Japanese patients with type 2 diabetes mellitus and diabetic nephropathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A randomized controlled study of finerenone versus placebo in Japanese patients with type 2 diabetes mellitus and diabetic nephropathy

Published:2017-04 Issue:4 Volume:31 Page:758-765
ISSN:1056-8727
Container-title:Journal of Diabetes and its Complications
language:en
Short-container-title:Journal of Diabetes and its Complications

Author:

Katayama Shigehiro,Yamada Daishiro,Nakayama Mikihiro,Yamada Takashi,Myoishi Masafumi,Kato Masaharu,Nowack Christina,Kolkhof Peter,Yamasaki Yoshimitsu

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference30 articles.

1. Standards of medical care in diabetes – 2014;American Diabetes Association;Diabetes Care,2014

2. Effect of finerenone on albuminuria in patients with diabetic nephropathy: A randomized clinical trial;Bakris;JAMA,2015

3. Effects of blood pressure level on progression of diabetic nephropathy: Results from the RENAAL study;Bakris;Archives of Internal Medicine,2003

4. Discovery of BAY 94-8862: A nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseases;Barfacker;ChemMedChem,2012

5. Aldosterone antagonists for preventing the progression of chronic kidney disease;Bolignano;Cochrane Database of Systematic Reviews,2014

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of finerenone in diabetic kidney disease patients: a real-world observational study from China;Renal Failure;2024-09-09

2. Early Clinical Experience of Finerenone in People with Chronic Kidney Disease and Type 2 Diabetes in Japan—A Multi-Cohort Study from the FOUNTAIN (FinerenOne mUltidatabase NeTwork for Evidence generAtIoN) Platform;Journal of Clinical Medicine;2024-08-28

3. A four-in-one first-in-human study to assess safety, tolerability, pharmacokinetics, pharmacodynamics, and concentration-QTc relationship of HRS-1780, a selective non-steroidal mineralocorticoid receptor antagonist, in healthy men;Expert Opinion on Investigational Drugs;2024-08-26

4. Therapeutic approaches and novel antifibrotic agents in renal fibrosis: A comprehensive review;Journal of Biochemical and Molecular Toxicology;2024-08

5. Comparative efficacy and safety of SGLT2is and ns-MRAs in patients with diabetic kidney disease: a systematic review and network meta-analysis;Frontiers in Endocrinology;2024-07-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3